Fourteen years of high-dose CHOP (ACVB regimen): Preliminary conclusions about the treatment of aggressive-lymphoma patients
- 1 March 1995
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 6 (3) , 211-217
- https://doi.org/10.1093/oxfordjournals.annonc.a059149
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.Journal of Clinical Oncology, 1994
- Risk of Leukemia Following Treatment for Non-Hodgkin's LymphomaJNCI Journal of the National Cancer Institute, 1994
- Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group.Journal of Clinical Oncology, 1993
- Prognostic variables in patients with diffuse large-cell lymphoma treated with MACOP-B.Journal of Clinical Oncology, 1991
- Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: A prospective study of 361 immunophenotyped patients treated with the LNH-84 regimenAnnals of Oncology, 1990
- Diffuse large cell lymphoma with discordant bone marrow histology. Clinical features and biological implicationsCancer, 1989
- Interpretation of clinical trials in diffuse large-cell lymphoma.Journal of Clinical Oncology, 1988
- Intensive chemotherapy in aggressive lymphomas: updated results of LNH- 80 protocol and prognostic factors affecting response and survivalBlood, 1987
- National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCancer, 1982
- Non-Hodgkin's lymphoma in children.A progress report on the original patients treated with the LSA2-L2 protocolCancer, 1979